Nosocomial Infection Caused by Methicillin-Resistant Staphylococcus aureus in Palestine
This report presents the prevalence of Palestinian isolates of methicillin-resistant Staphylococcus aureus (MRSA) in nosocomial infections and their antibiotic resistant pattern. A total of 321 clinical isolates of S. aureus were identified from different patients. The prevalence of methicillin resi...
Gespeichert in:
| Veröffentlicht in: | Microbial drug resistance (Larchmont, N.Y.) N.Y.), 2005-03, Vol.11 (1), p.75-77 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 77 |
|---|---|
| container_issue | 1 |
| container_start_page | 75 |
| container_title | Microbial drug resistance (Larchmont, N.Y.) |
| container_volume | 11 |
| creator | Adwan, K. Abu-Hasan, N. Adwan, G. Jarrar, N. Abu-Shanab, B. Abu-Zant, A. |
| description | This report presents the prevalence of Palestinian isolates of methicillin-resistant
Staphylococcus aureus
(MRSA) in nosocomial infections and their antibiotic resistant pattern. A total of 321 clinical isolates of
S. aureus
were identified from different patients. The prevalence of methicillin resistance among
S. aureus
isolates was 8.7% (28 isolates). Resistance rates of MRSA to other antibiotics were as follows: 82.1% resistant to erythromycin, 67.9% to clindamycin, 64.3% to gentamicin, and 32.1% to ciprofloxacin. No co-trimoxazole- and vancomycin-resistant isolates were identified in this study. The proportion of methicillin resistance was highest among
S. aureus
isolates associated with upper respiratory specimens (42.8%); the proportion of methicillin resistance was 39.3% among skin ulcer isolates, 10.7% among urinary tract infection isolates, and lowest among isolates associated with blood and prostate discharge (3.6% each). |
| doi_str_mv | 10.1089/mdr.2005.11.75 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67520513</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67520513</sourcerecordid><originalsourceid>FETCH-LOGICAL-c388t-32cd29d2e03601d9680a9c6ba0361a52548832784f699f800cae5d44358e24e3</originalsourceid><addsrcrecordid>eNqF0c9r2zAUB3BRNpq263XHYXboqfb029JxhLYrtOvYCjsKRX4mKrKcSfYh_30VEjrIpacnic974vFF6DPBDcFKfxu61FCMRUNI04oTdEY0I7XiXH0oZ9zKWlLNF-g85xdcHJHsFC2IaFuMtT5Df3-OeXTj4G2o7mMPbvJjrJZ2ztBVq231CNPaOx-Cj_VvyD5PNk7Vn8lu1ttQGp2bc2XnBKX4WP2yAfLkI3xCH3sbMlwe6gV6vr15Xv6oH57u7pffH2rHlJpqRl1HdUcBM4lJp6XCVju5suVOrKCCK8Voq3gvte4Vxs6C6DhnQgHlwC7Q1X7sJo3_5vK1GXx2EIKNMM7ZyFbQsjR7F5JWSaU4KfDrEXwZ5xTLDoZirqmWWhXU7JFLY84JerNJfrBpawg2u1xMycXscjGEmFaUhi-HqfNqgO4_PwRRwPUe7J5tjMHDCtL0Bo_mvQK-iJfT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204929698</pqid></control><display><type>article</type><title>Nosocomial Infection Caused by Methicillin-Resistant Staphylococcus aureus in Palestine</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>Adwan, K. ; Abu-Hasan, N. ; Adwan, G. ; Jarrar, N. ; Abu-Shanab, B. ; Abu-Zant, A.</creator><creatorcontrib>Adwan, K. ; Abu-Hasan, N. ; Adwan, G. ; Jarrar, N. ; Abu-Shanab, B. ; Abu-Zant, A.</creatorcontrib><description>This report presents the prevalence of Palestinian isolates of methicillin-resistant
Staphylococcus aureus
(MRSA) in nosocomial infections and their antibiotic resistant pattern. A total of 321 clinical isolates of
S. aureus
were identified from different patients. The prevalence of methicillin resistance among
S. aureus
isolates was 8.7% (28 isolates). Resistance rates of MRSA to other antibiotics were as follows: 82.1% resistant to erythromycin, 67.9% to clindamycin, 64.3% to gentamicin, and 32.1% to ciprofloxacin. No co-trimoxazole- and vancomycin-resistant isolates were identified in this study. The proportion of methicillin resistance was highest among
S. aureus
isolates associated with upper respiratory specimens (42.8%); the proportion of methicillin resistance was 39.3% among skin ulcer isolates, 10.7% among urinary tract infection isolates, and lowest among isolates associated with blood and prostate discharge (3.6% each).</description><identifier>ISSN: 1076-6294</identifier><identifier>EISSN: 1931-8448</identifier><identifier>DOI: 10.1089/mdr.2005.11.75</identifier><identifier>PMID: 15770099</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Antibiotic resistance ; Antibiotics ; Blood ; Cross Infection - epidemiology ; Cross Infection - microbiology ; Disease ; Drug resistance ; Drug Resistance, Bacterial ; Humans ; Infections ; Methicillin Resistance ; Nosocomial infection ; Prevalence ; Staphylococcal Infections - drug therapy ; Staphylococcal Infections - epidemiology ; Staphylococcal Infections - microbiology ; Staphylococcus aureus ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - isolation & purification ; Staphylococcus aureus - physiology</subject><ispartof>Microbial drug resistance (Larchmont, N.Y.), 2005-03, Vol.11 (1), p.75-77</ispartof><rights>2005, Mary Ann Liebert, Inc.</rights><rights>(©) Copyright 2005, Mary Ann Liebert, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c388t-32cd29d2e03601d9680a9c6ba0361a52548832784f699f800cae5d44358e24e3</citedby><cites>FETCH-LOGICAL-c388t-32cd29d2e03601d9680a9c6ba0361a52548832784f699f800cae5d44358e24e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.liebertpub.com/doi/epdf/10.1089/mdr.2005.11.75$$EPDF$$P50$$Gmaryannliebert$$H</linktopdf><linktohtml>$$Uhttps://www.liebertpub.com/doi/full/10.1089/mdr.2005.11.75$$EHTML$$P50$$Gmaryannliebert$$H</linktohtml><link.rule.ids>314,780,784,3042,21723,27924,27925,55291,55303</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15770099$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adwan, K.</creatorcontrib><creatorcontrib>Abu-Hasan, N.</creatorcontrib><creatorcontrib>Adwan, G.</creatorcontrib><creatorcontrib>Jarrar, N.</creatorcontrib><creatorcontrib>Abu-Shanab, B.</creatorcontrib><creatorcontrib>Abu-Zant, A.</creatorcontrib><title>Nosocomial Infection Caused by Methicillin-Resistant Staphylococcus aureus in Palestine</title><title>Microbial drug resistance (Larchmont, N.Y.)</title><addtitle>Microb Drug Resist</addtitle><description>This report presents the prevalence of Palestinian isolates of methicillin-resistant
Staphylococcus aureus
(MRSA) in nosocomial infections and their antibiotic resistant pattern. A total of 321 clinical isolates of
S. aureus
were identified from different patients. The prevalence of methicillin resistance among
S. aureus
isolates was 8.7% (28 isolates). Resistance rates of MRSA to other antibiotics were as follows: 82.1% resistant to erythromycin, 67.9% to clindamycin, 64.3% to gentamicin, and 32.1% to ciprofloxacin. No co-trimoxazole- and vancomycin-resistant isolates were identified in this study. The proportion of methicillin resistance was highest among
S. aureus
isolates associated with upper respiratory specimens (42.8%); the proportion of methicillin resistance was 39.3% among skin ulcer isolates, 10.7% among urinary tract infection isolates, and lowest among isolates associated with blood and prostate discharge (3.6% each).</description><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Blood</subject><subject>Cross Infection - epidemiology</subject><subject>Cross Infection - microbiology</subject><subject>Disease</subject><subject>Drug resistance</subject><subject>Drug Resistance, Bacterial</subject><subject>Humans</subject><subject>Infections</subject><subject>Methicillin Resistance</subject><subject>Nosocomial infection</subject><subject>Prevalence</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal Infections - epidemiology</subject><subject>Staphylococcal Infections - microbiology</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - isolation & purification</subject><subject>Staphylococcus aureus - physiology</subject><issn>1076-6294</issn><issn>1931-8448</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqF0c9r2zAUB3BRNpq263XHYXboqfb029JxhLYrtOvYCjsKRX4mKrKcSfYh_30VEjrIpacnic974vFF6DPBDcFKfxu61FCMRUNI04oTdEY0I7XiXH0oZ9zKWlLNF-g85xdcHJHsFC2IaFuMtT5Df3-OeXTj4G2o7mMPbvJjrJZ2ztBVq231CNPaOx-Cj_VvyD5PNk7Vn8lu1ttQGp2bc2XnBKX4WP2yAfLkI3xCH3sbMlwe6gV6vr15Xv6oH57u7pffH2rHlJpqRl1HdUcBM4lJp6XCVju5suVOrKCCK8Voq3gvte4Vxs6C6DhnQgHlwC7Q1X7sJo3_5vK1GXx2EIKNMM7ZyFbQsjR7F5JWSaU4KfDrEXwZ5xTLDoZirqmWWhXU7JFLY84JerNJfrBpawg2u1xMycXscjGEmFaUhi-HqfNqgO4_PwRRwPUe7J5tjMHDCtL0Bo_mvQK-iJfT</recordid><startdate>20050301</startdate><enddate>20050301</enddate><creator>Adwan, K.</creator><creator>Abu-Hasan, N.</creator><creator>Adwan, G.</creator><creator>Jarrar, N.</creator><creator>Abu-Shanab, B.</creator><creator>Abu-Zant, A.</creator><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20050301</creationdate><title>Nosocomial Infection Caused by Methicillin-Resistant Staphylococcus aureus in Palestine</title><author>Adwan, K. ; Abu-Hasan, N. ; Adwan, G. ; Jarrar, N. ; Abu-Shanab, B. ; Abu-Zant, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c388t-32cd29d2e03601d9680a9c6ba0361a52548832784f699f800cae5d44358e24e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Blood</topic><topic>Cross Infection - epidemiology</topic><topic>Cross Infection - microbiology</topic><topic>Disease</topic><topic>Drug resistance</topic><topic>Drug Resistance, Bacterial</topic><topic>Humans</topic><topic>Infections</topic><topic>Methicillin Resistance</topic><topic>Nosocomial infection</topic><topic>Prevalence</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal Infections - epidemiology</topic><topic>Staphylococcal Infections - microbiology</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - isolation & purification</topic><topic>Staphylococcus aureus - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adwan, K.</creatorcontrib><creatorcontrib>Abu-Hasan, N.</creatorcontrib><creatorcontrib>Adwan, G.</creatorcontrib><creatorcontrib>Jarrar, N.</creatorcontrib><creatorcontrib>Abu-Shanab, B.</creatorcontrib><creatorcontrib>Abu-Zant, A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Microbial drug resistance (Larchmont, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adwan, K.</au><au>Abu-Hasan, N.</au><au>Adwan, G.</au><au>Jarrar, N.</au><au>Abu-Shanab, B.</au><au>Abu-Zant, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nosocomial Infection Caused by Methicillin-Resistant Staphylococcus aureus in Palestine</atitle><jtitle>Microbial drug resistance (Larchmont, N.Y.)</jtitle><addtitle>Microb Drug Resist</addtitle><date>2005-03-01</date><risdate>2005</risdate><volume>11</volume><issue>1</issue><spage>75</spage><epage>77</epage><pages>75-77</pages><issn>1076-6294</issn><eissn>1931-8448</eissn><abstract>This report presents the prevalence of Palestinian isolates of methicillin-resistant
Staphylococcus aureus
(MRSA) in nosocomial infections and their antibiotic resistant pattern. A total of 321 clinical isolates of
S. aureus
were identified from different patients. The prevalence of methicillin resistance among
S. aureus
isolates was 8.7% (28 isolates). Resistance rates of MRSA to other antibiotics were as follows: 82.1% resistant to erythromycin, 67.9% to clindamycin, 64.3% to gentamicin, and 32.1% to ciprofloxacin. No co-trimoxazole- and vancomycin-resistant isolates were identified in this study. The proportion of methicillin resistance was highest among
S. aureus
isolates associated with upper respiratory specimens (42.8%); the proportion of methicillin resistance was 39.3% among skin ulcer isolates, 10.7% among urinary tract infection isolates, and lowest among isolates associated with blood and prostate discharge (3.6% each).</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>15770099</pmid><doi>10.1089/mdr.2005.11.75</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1076-6294 |
| ispartof | Microbial drug resistance (Larchmont, N.Y.), 2005-03, Vol.11 (1), p.75-77 |
| issn | 1076-6294 1931-8448 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67520513 |
| source | Mary Ann Liebert Online Subscription; MEDLINE |
| subjects | Antibiotic resistance Antibiotics Blood Cross Infection - epidemiology Cross Infection - microbiology Disease Drug resistance Drug Resistance, Bacterial Humans Infections Methicillin Resistance Nosocomial infection Prevalence Staphylococcal Infections - drug therapy Staphylococcal Infections - epidemiology Staphylococcal Infections - microbiology Staphylococcus aureus Staphylococcus aureus - drug effects Staphylococcus aureus - isolation & purification Staphylococcus aureus - physiology |
| title | Nosocomial Infection Caused by Methicillin-Resistant Staphylococcus aureus in Palestine |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T20%3A05%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nosocomial%20Infection%20Caused%20by%20Methicillin-Resistant%20Staphylococcus%20aureus%20in%20Palestine&rft.jtitle=Microbial%20drug%20resistance%20(Larchmont,%20N.Y.)&rft.au=Adwan,%20K.&rft.date=2005-03-01&rft.volume=11&rft.issue=1&rft.spage=75&rft.epage=77&rft.pages=75-77&rft.issn=1076-6294&rft.eissn=1931-8448&rft_id=info:doi/10.1089/mdr.2005.11.75&rft_dat=%3Cproquest_cross%3E67520513%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204929698&rft_id=info:pmid/15770099&rfr_iscdi=true |